Introduction: Bladder tamponade is an uncommon complication of post-TURP bleeding and, for its resolution, it may require a long and complex process when conducted transurethrally.
Material And Methods: From 2001 to 2011, 20 patients were treated endoscopically by transurethral combined use of Amplatz percutaneous suprapubic cannula. Blood clots were detected above the average size of 5 cm. The technique has required a transurethral access with resector, dissection and resection of clots. In cases where the techniquet has proved insufficient, an Amplatz cannula was introduced by suprapubic access. The resector allows controlling the technique and a constant irrigation, and is also necessary for the final evaluation of the clinical picture. The procedure has been completed with the application of a suprapubic catheter left in site for 24 hours, together with a transurethral one for 48 hours.
Results: In all the cases that we treated, the condition was solved between 15 and 25 minutes, and the evacuation of blood clots was entirely performed. There were no complications. The final control by transurethral way allowed executing hemostasis in all cases. The post-TURP vesical tamponade can represent a dramatic event in terms of pain and alteration of renal function for patients with renal insufficiency. The combined technique, which might appear bloody, represents a valid alternative to the classic transurethral endoscopic technique, which still represents the gold standard in the case of small bleeding and not organized blood clots.
Conclusions: The use of a suprapubic approach with this technique allows for a rapid, efficient and secure resolution of, otherwise, a long and difficultly treatable disease as it is the case with bladder tamponade due to clots for non-neoplastic diseases.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.5301/RU.2012.9732 | DOI Listing |
J Vasc Surg Cases Innov Tech
April 2024
Section of Cardiothoracic Surgery, Department of Surgery, Ochsner Health, New Orleans, LA.
Left ventricular assist devices are known for the treatment of heart failure. We present a patient who underwent emergent decommissioning of his left ventricular assist device after experiencing life-threatening hemorrhage. In this case, the patient's outflow graft was avulsed from his left subclavian artery.
View Article and Find Full Text PDFSemin Thorac Cardiovasc Surg
October 2020
Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, Nebraska. Electronic address:
Left ventricular assist device (LVAD) deactivation may be considered in cases of left ventricular recovery, pump thrombosis, infection, and end-of-life palliation. Surgical pump explantation remains the principal method, but percutaneous deactivation presents a safe and effective alternative. We have developed a formal program for percutaneous LVAD deactivation within our advanced heart failure program including patient selection criteria, preprocedure testing, a procedural algorithm, and a postprocedure care plan.
View Article and Find Full Text PDFJ Cardiothorac Surg
September 2019
Department of Cardiovascular Surgery, Yokohama City University, Fukuura 3-9, Kanazawa-ku, Yokohama, Kanagawa, 236-0008, Japan.
Background: Aortic erosion is a serious complication that usually occurs shortly after Amplazter Septal Occluder (ASO) implantation for atrial septal defect (ASD).
Case Presentation: A seven-year-old girl was diagnosed with secundum ASD without symptoms. Transesophageal echocardiography (TEE) showed a defect of 20 mm in diameter in the fossa ovalis without aortic rim.
Catheter Cardiovasc Interv
December 2019
Department of Pediatrics, University of Cincinnati College of Medicine, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Objectives: To describe a novel technique for mechanical thrombectomy (MT) in young children.
Background: Acute thrombosis in children may be a cause of significant morbidity or mortality. MT options in children are limited due to patient and vessel size, prompting consideration of innovative approaches.
Indian J Urol
April 2016
Department of Urology, Global Rainbow Hospital, Agra, Uttar Pradesh, India.
Introduction: Percutaneous nephrolithotomy (PCNL) has witnessed rapid advancements, the latest being ultra-mini-percutaneous nephrolithotomy (UMP), which makes the use of 11-13F sheaths as compared to 24-30F sizes used in conventional PCNL. This miniaturization aims to reduce morbidity and improve patient outcomes. We evaluated the safety and efficacy of UMP and report our ourtcomes.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!